Causes of Hypercalcemia
The two most common causes of hypercalcemia are primary hyperparathyroidism (PHPT) and malignancy, accounting for approximately 90% of all cases 1. The diagnostic approach hinges on measuring serum PTH levels to distinguish PTH-dependent from PTH-independent etiologies 2.
Algorithmic Approach Based on PTH Levels
Hypercalcemia with Elevated or Normal PTH (PTH-Dependent)
Primary hyperparathyroidism is the predominant cause when PTH is elevated or inappropriately normal in the setting of hypercalcemia 1. This represents the most common etiology in outpatient settings, affecting approximately 1% of the population 1.
- Primary hyperparathyroidism (PHPT): Most frequent cause overall, characterized by autonomous PTH secretion from parathyroid adenoma, hyperplasia, or rarely carcinoma
- Familial hypocalciuric hypercalcemia (FHH): Genetic disorder due to inactivating mutations in CASR, GNA11, or AP2S1 genes, presenting with hypercalcemia and inappropriately normal or elevated PTH 2
- Parathyroid carcinoma: Rare malignant cause requiring combined treatment with calcimimetics and antiresorptive agents 3
Critical pitfall: FHH can be mistaken for PHPT. The key distinguishing feature is that FHH patients have normal calciuria (not truly "hypocalciuric"), though this overlap makes genetic testing essential when suspected 2, 4.
Hypercalcemia with Suppressed or Low PTH (PTH-Independent)
When PTH is suppressed (<20 pg/mL), six main categories must be considered: malignant, granulomatous, genetic, immobilization-related, endocrine, or drug-induced 2.
Malignancy-Related Causes
Malignancy is the leading cause of hypercalcemia in hospitalized patients 1. Two distinct mechanisms exist:
- Humoral hypercalcemia of malignancy: PTHrP secretion by solid tumors (epidermoid, neuroendocrine), causing hypercalcemia with hypophosphatemia due to proximal tubular effects 2
- Local osteolytic hypercalcemia: Direct bone destruction from metastases (breast cancer) or myeloma, typically associated with hyperphosphatemia 2
The phosphate level differentiates these mechanisms: hypophosphatemia suggests PTHrP-mediated disease, while hyperphosphatemia indicates osteolytic metastases 2.
Vitamin D-Related Causes
Hypervitaminosis D induces hypercalcemia through three mechanisms 2:
- Excessive supplementation: Increasingly common with overzealous vitamin D replacement 5
- Granulomatous production: Unregulated calcitriol production by macrophages in sarcoidosis, tuberculosis, lymphoma, or pneumocystosis via extra-renal 1-alpha-hydroxylase 2
- Genetic catabolism defects: CYP24A1 gene variants causing childhood idiopathic hypercalcemia type 1 with impaired vitamin D breakdown 2
Important note: Vitamin D toxicity was the second most common cause of hypercalcemia (24.8%) in one recent series, highlighting its emerging importance 5.
Genetic Causes (PTH-Independent)
Multiple rare genetic syndromes cause hypercalcemia with suppressed PTH 2:
- Williams-Beuren syndrome: Chromosome 7 microdeletion causing infantile hypercalcemia (15% of cases), resolving by age 4, with mental retardation and cardiovascular abnormalities 2
- Jansen's metaphyseal chondrodysplasia: Activating PTH1R gene variants causing hypercalcemia between 1 month and 10 years of age 2
- Mahvash syndrome: Glucagon receptor (GCGR) gene variants 2
- Hypophosphatasia: ALPL gene mutation with hypercalcemia, hyperphosphatemia, and low alkaline phosphatase 2
- Congenital lactose intolerance: Lactase/iso-maltase deficiency with increased intestinal calcium absorption 2
Immobilization Hypercalcemia
Immobilization causes hypercalcemia through reduced mechanical stimulation of osteoblasts, increasing sclerostin and favoring osteoclastic resorption 2. This occurs:
- In young adults 4-6 weeks after spinal cord trauma
- In elderly poly-pathological patients weeks to months after immobilization onset 2
Endocrine Causes
Several endocrinopathies induce hypercalcemia with suppressed PTH 2:
- Hyperthyroidism: Direct thyroid hormone action on bone resorption
- Acute adrenal insufficiency: Hypercalcemia (typically <3 mmol/L) from dehydration and metabolic acidosis
- Pheochromocytoma: Direct catecholamine effects on bone or PTHrP secretion
- Acromegaly: Increased calcitriol production, occasionally causing hypercalcemic tendency
Other Important Causes
- Cirrhosis: Hypercalcemia without increased PTH or vitamin D, associated with increased mortality, likely from inflammatory cytokines and prostaglandins 2
- Medications: Thiazide diuretics, lithium, calcium supplements, vitamin A, denosumab discontinuation 1, 6
- Milk-alkali syndrome: Excessive calcium and alkali intake 7
Essential Diagnostic Workup
Before attributing hypercalcemia to any specific cause, rule out confounding factors 2, 4:
- Vitamin D deficiency: Measure 25-OH vitamin D
- Renal insufficiency: Calculate eGFR
- Malabsorption: Screen for inflammatory bowel disease, celiac disease, bariatric surgery history
- Dietary factors: Assess calcium intake
- Medications: Review thiazides, lithium, bisphosphonates, denosumab, corticosteroids, excessive vitamin D/calcium supplementation
These factors can mask or induce hypercalcemia and must be addressed before definitive diagnosis 2, 4.
Clinical Severity Classification
Hypercalcemia severity determines urgency of intervention 1:
- Mild: Total calcium <12 mg/dL (<3 mmol/L) - usually asymptomatic, may have fatigue and constipation in 20%
- Moderate: 12-14 mg/dL (3-3.5 mmol/L)
- Severe: >14 mg/dL (>3.5 mmol/L) - causes nausea, vomiting, dehydration, confusion, somnolence, coma
Symptom severity relates to both absolute calcium level and rapidity of rise 1.